{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:59:43Z","timestamp":1757311183991,"version":"3.40.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T00:00:00Z","timestamp":1349308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00204-012-0947-7","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T14:57:22Z","timestamp":1349276242000},"page":"469-479","source":"Crossref","is-referenced-by-count":6,"title":["Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats"],"prefix":"10.1007","volume":"87","author":[{"given":"Yih-Shou","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Hsien","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yih","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,4]]},"reference":[{"key":"947_CR1","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.1523\/JNEUROSCI.2552-05.2005","volume":"25","author":"C Acuna-Goycolea","year":"2005","unstructured":"Acuna-Goycolea C, van den Pol AN (2005) Peptide YY(3\u201336) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J Neurosci 25:10510\u201310519","journal-title":"J Neurosci"},{"key":"947_CR2","first-page":"113","volume":"60","author":"G Biala","year":"2009","unstructured":"Biala G, Kruk M, Budzynska B (2009) Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. J Physiol Pharmacol 60:113\u2013122","journal-title":"J Physiol Pharmacol"},{"key":"947_CR3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","volume":"2","author":"SP Brothers","year":"2010","unstructured":"Brothers SP, Wahlestedt C (2010) Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Mol Med 2:429\u2013439","journal-title":"EMBO Mol Med"},{"key":"947_CR4","doi-asserted-by":"crossref","first-page":"33337","DOI":"10.1074\/jbc.M804671200","volume":"283","author":"MJ Chee","year":"2008","unstructured":"Chee MJ, M\u00f6rl K, Lindner D, Merten N, Zamponi GW, Light PE, Beck-Sickinger AG, Colmers WF (2008) The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptor. J Biol Chem 283:33337\u201333346","journal-title":"J Biol Chem"},{"key":"947_CR5","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1523\/JNEUROSCI.4031-09.2010","volume":"30","author":"MJ Chee","year":"2010","unstructured":"Chee MJ, Myers MG Jr, Price CJ, Colmers WF (2010) Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus. J Neurosci 30:3380\u20133390","journal-title":"J Neurosci"},{"key":"947_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0304-3940(03)00637-2","volume":"347","author":"JT Cheng","year":"2003","unstructured":"Cheng JT, Kuo DY (2003) Both a1-adrenergic and D1-dopaminergic neurotransmissions are involved in phenylpropanolaminemediated feeding suppression in mice. Neurosci Lett 347:136\u2013138","journal-title":"Neurosci Lett"},{"key":"947_CR7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/npp.2011.230","volume":"37","author":"H Cohen","year":"2012","unstructured":"Cohen H, Liu T, Kozlovsky N, Kaplan Z, Zohar J, Math\u00e9 AA (2012) The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 37:350\u2013363","journal-title":"Neuropsychopharmacology"},{"key":"947_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2009.12.088","volume":"1318","author":"GS Deo","year":"2010","unstructured":"Deo GS, Dandekar MP, Upadhya MA, Kokare DM, Subhedar NK (2010) Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: behavioral and immunocytochemical evidences. Brain Res 1318:77\u201386","journal-title":"Brain Res"},{"key":"947_CR9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yfrne.2006.07.002","volume":"27","author":"C Eva","year":"2006","unstructured":"Eva C, Serra M, Mele P, Panzica G, Oberto A (2006) Physiology and gene regulation of the brain NPY Y1 receptor. Front Neuroendocrinol 27:308\u2013339","journal-title":"Front Neuroendocrinol"},{"key":"947_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/382168a0","volume":"382","author":"C Gerald","year":"1996","unstructured":"Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE et al (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382:168\u2013171","journal-title":"Nature"},{"key":"947_CR11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1176\/appi.ajp.157.6.1021-a","volume":"157","author":"A Goodhue","year":"2000","unstructured":"Goodhue A, Bartel RL, Smith NB (2000) Exacerbation of psychosis by phenylpropanolamine. Am J Psychiatry 157:1021\u20131022","journal-title":"Am J Psychiatry"},{"key":"947_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-0115(95)00103-I","volume":"59","author":"M Heilig","year":"1995","unstructured":"Heilig M (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59:201\u2013205","journal-title":"Regul Pept"},{"key":"947_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/REVNEURO.2002.13.1.85","volume":"13","author":"M Heilig","year":"2002","unstructured":"Heilig M, Thorsell A (2002) Brain neuropeptide Y (NPY) in stress and alcohol dependence. Rev Neurosci 13:85\u201394","journal-title":"Rev Neurosci"},{"key":"947_CR14","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.3748\/wjg.14.6312","volume":"14","author":"H Higuchi","year":"2008","unstructured":"Higuchi H, Niki T, Shiiya T (2008) Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y Y5 receptor subclass. World J Gastroenterol 14:6312\u20136317","journal-title":"World J Gastroenterol"},{"key":"947_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tem.2008.10.003","volume":"20","author":"TL Horvath","year":"2009","unstructured":"Horvath TL, Andrews ZB, Diano S (2009) Fuel utilization by hypothalamic neurons: roles for ROS. Trends Endocrinol Metab 20:78\u201387","journal-title":"Trends Endocrinol Metab"},{"key":"947_CR16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1037\/0735-7044.121.5.933","volume":"121","author":"YS Hsieh","year":"2007","unstructured":"Hsieh YS, Yang SF, Chiou HL, Kuo DY (2007a) Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression. Behav Neurosci 121:933\u2013940","journal-title":"Behav Neurosci"},{"key":"947_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1152\/ajpendo.00195.2006","volume":"292","author":"YS Hsieh","year":"2007","unstructured":"Hsieh YS, Yang SF, Kuo DY (2007b) Intracerebral administration of protein kinase A (PKA) or c-AMP response element binding protein (CREB) antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats. Am J Physiol Endocrinol Metab 292:123\u2013131","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"947_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-4159.2007.04919.x","volume":"104","author":"YS Hsieh","year":"2008","unstructured":"Hsieh YS, Yang SF, Chu SC, Kuo DY (2008a) Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine. J Neurochem 104:50\u201361","journal-title":"J Neurochem"},{"key":"947_CR19","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/j.1471-4159.2008.05246.x","volume":"105","author":"YS Hsieh","year":"2008","unstructured":"Hsieh YS, Yang SF, Chu SC, Ho YJ, Kuo CS, Kuo DY (2008b) Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats. J Neurochem 105:1438\u20131449","journal-title":"J Neurochem"},{"key":"947_CR20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/0269881110376692","volume":"25","author":"YS Hsieh","year":"2011","unstructured":"Hsieh YS, Yang SF, Chen PN, Chu SC, Chen CH, Kuo DY (2011) Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats. J Psychopharm 25:982\u2013994","journal-title":"J Psychopharm"},{"key":"947_CR21","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/db08-1039","volume":"58","author":"T Jaillard","year":"2009","unstructured":"Jaillard T, Roger M, Galinier A, Guillou P, Benani A, Leloup C et al (2009) Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: an NADPH oxidasedependent mechanism. Diabetes 58:1544\u20131549","journal-title":"Diabetes"},{"key":"947_CR22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.2009.05909.x","volume":"108","author":"DY Kuo","year":"2009","unstructured":"Kuo DY, Yang SF, Chu SC, Chen CH, Hsieh YS (2009) Roles of protein kinase C-\u03b1 isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression. J Neurochem 108:1495\u20131506","journal-title":"J Neurochem"},{"key":"947_CR23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1471-4159.2010.06843.x","volume":"114","author":"DY Kuo","year":"2010","unstructured":"Kuo DY, Yang SF, Chu SC, Chen CH, Chen PN, Hsieh YS (2010) The effect of protein kinase C-delta knockdown on anti-free radical enzyme and neuropeptide Y gene expression in phenylpropanolamine-treated rats. J Neurochem 114:1217\u20131230","journal-title":"J Neurochem"},{"key":"947_CR24","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1089\/ars.2010.3738","volume":"15","author":"DY Kuo","year":"2011","unstructured":"Kuo DY, Chen PN, Yang SF, Chu SC, Chen CH, Kuo MS, Yu CH, Hsieh YS (2011) Role of reactive oxygen species-related enzymes in neuropeptide Y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown. Antioxid Redox Signal 15:2147\u20132159","journal-title":"Antioxid Redox Signal"},{"key":"947_CR25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00204-011-0761-7","volume":"86","author":"DY Kuo","year":"2012","unstructured":"Kuo DY, Chen PN, Chu SC, Hsieh YS (2012a) Knocking down the transcript of NF-kappaB modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats. Arch Toxicol 86:453\u2013463","journal-title":"Arch Toxicol"},{"key":"947_CR26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuropharm.2012.06.018","volume":"63","author":"DY Kuo","year":"2012","unstructured":"Kuo DY, Chen PN, Yu CH, Kuo MH, Hsieh YS, Chu SC (2012b) Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression. Neuropharmacology 63:842\u2013850","journal-title":"Neuropharmacology"},{"key":"947_CR27","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1073\/pnas.95.26.15659","volume":"95","author":"A Kushi","year":"1998","unstructured":"Kushi A, Sasai H, Koizumi H, Takeda N, Yokoyama M, Nakamura M (1998) Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor deficient mice. Proc Natl Acad Sci USA 95:15659\u201315664","journal-title":"Proc Natl Acad Sci USA"},{"key":"947_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2826.1994.tb00566.x","volume":"6","author":"PJ Larsen","year":"1994","unstructured":"Larsen PJ, Jessop DS, Chowdrey HS, Lightman SL, Mikkelsen JD (1994) Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol 6:153\u2013159","journal-title":"J Neuroendocrinol"},{"key":"947_CR29","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2174\/156802607782341028","volume":"7","author":"DJ MacNeil","year":"2007","unstructured":"MacNeil DJ (2007) NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs. Curr Top Med Chem 7:1721\u20131733","journal-title":"Curr Top Med Chem"},{"key":"947_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2009.05.018","volume":"615","author":"S Mashiko","year":"2009","unstructured":"Mashiko S, Moriya R, Ishihara A, Gomori A, Matsushita H, Egashira S, Iwaasa H, Takahashi T, Haga Y, Fukami T, Kanatani A (2009) Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. Eur J Pharmacol 615:113\u2013117","journal-title":"Eur J Pharmacol"},{"key":"947_CR31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.yfrne.2011.06.001","volume":"32","author":"RE Mercer","year":"2011","unstructured":"Mercer RE, Chee MJ, Colmers WF (2011) The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol 32:398\u2013415 (review)","journal-title":"Front Neuroendocrinol"},{"key":"947_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","volume":"50","author":"MC Michel","year":"1998","unstructured":"Michel MC, Beck-Sickinger A, Cox HXVI et al (1998) International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143\u2013150","journal-title":"Pharmacol Rev"},{"key":"947_CR33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MED.0b013e3283422f0a","volume":"18","author":"AD Nguyen","year":"2011","unstructured":"Nguyen AD, Herzog H, Sainsbury A (2011) Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes 18:56\u201360","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"947_CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/chemse\/23.2.249","volume":"23","author":"S Ogawa","year":"1998","unstructured":"Ogawa S, Pfaff DW (1998) Current status of antisense DNA methods in behavioral studies. Chem Senses 23:249\u2013255","journal-title":"Chem Senses"},{"key":"947_CR35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/en.138.1.196","volume":"138","author":"D O\u2019Shea","year":"1997","unstructured":"O\u2019Shea D, Morgan DG, Meeran K, Edwards CM, Turton MD, Choi SJ (1997) Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 138:196\u2013202","journal-title":"Endocrinology"},{"key":"947_CR36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0165-6147(03)00226-8","volume":"24","author":"SC Pandey","year":"2003","unstructured":"Pandey SC (2003) Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci 24:456\u2013460","journal-title":"Trends Pharmacol Sci"},{"key":"947_CR37","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney","edition":"2"},{"key":"947_CR38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1369-1600.2008.00101.x","volume":"13","author":"JH Penzner","year":"2008","unstructured":"Penzner JH, Thompson DL, Arth C, Fowler JK, Ary AW, Szumlinski KK (2008) Protracted \u2018anti-addictive\u2019 effects of adolescent phenylpropanolamine exposure in C57BL\/6J mice. Addict Biol 13:310\u2013325","journal-title":"Addict Biol"},{"key":"947_CR39","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2460\/javma.239.11.1463","volume":"239","author":"KL Peterson","year":"2011","unstructured":"Peterson KL, Lee JA, Hovda LR (2011) Phenylpropanolamine toxicosis in dogs: 170 cases (2004\u20132009). J Am Vet Med Assoc 239:1463\u20131469","journal-title":"J Am Vet Med Assoc"},{"key":"947_CR40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mhl.2003.27","volume":"32","author":"FH Pilsczek","year":"2003","unstructured":"Pilsczek FH, Karcic AA, Freeman I (2003) Case report: dexatrim (phenylpropanolamine) as a cause of myocardial infarction. Heart Lung 32:100\u2013104","journal-title":"Heart Lung"},{"key":"947_CR41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1126\/science.6264602","volume":"213","author":"RC Ritter","year":"1981","unstructured":"Ritter RC, Slusser PG, Stone S (1981) Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213:451\u2013452","journal-title":"Science"},{"key":"947_CR42","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0014-2999(94)90822-2","volume":"271","author":"K Rudolf","year":"1994","unstructured":"Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M et al (1994) The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP 3226. Eur J Pharmacol 271:R11\u2013R13","journal-title":"Eur J Pharmacol"},{"key":"947_CR43","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1517\/13543770903251722","volume":"19","author":"N Sato","year":"2009","unstructured":"Sato N, Ogino Y, Mashiko S, Ando M (2009) Modulation of neuropeptide Y receptors for the treatment of obesity. Expert Opin Ther Pat 19:1401\u20131415","journal-title":"Expert Opin Ther Pat"},{"key":"947_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(97)01014-5","volume":"331","author":"B Sch\u00f6bitz","year":"1997","unstructured":"Sch\u00f6bitz B, Pezeshki G, Probst JC, Reul JM, Skutella T, St\u00f6hr T, Holsboer F, Spanagel R (1997) Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effects. Eur J Pharmacol 331:97\u2013107","journal-title":"Eur J Pharmacol"},{"key":"947_CR45","first-page":"160","volume":"58","author":"M Seif-El-Nasr","year":"2008","unstructured":"Seif-El-Nasr M, Atia AS (2008) Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant. Arzneimittelforschung 58:160\u2013167","journal-title":"Arzneimittelforschung"},{"key":"947_CR46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0167-0115(98)00083-4","volume":"75\u201376","author":"S Sheriff","year":"1998","unstructured":"Sheriff S, Dayal R, Kasckow J, Regmi A, Chance W, Fischer J, Balasubramaniam A (1998) NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines bearing Y1 and Y2 receptors: involvement of CREB. Regul Pept 75\u201376:309\u2013318","journal-title":"Regul Pept"},{"key":"947_CR47","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1301306","volume":"32","author":"KK Szumlinski","year":"2007","unstructured":"Szumlinski KK, Liu A, Penzner JH, Lominac KD (2007) Protracted \u2018pro-addictive\u2019 phenotype produced in mice by preadolescent phenylpropanolamine. Neuropsychopharmacology 32:1760\u20131773","journal-title":"Neuropsychopharmacology"},{"key":"947_CR48","first-page":"274","volume":"44","author":"K Toll","year":"2006","unstructured":"Toll K, Graf P (2006) Phenylpropanolamine\u2019s decongestive effect on the nasalmucosa of pregnant women with nasal stuffiness. Rhinology 44:274\u2013277","journal-title":"Rhinology"},{"key":"947_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eururo.2007.09.037","volume":"53","author":"P Tsakiris","year":"2008","unstructured":"Tsakiris P, de la Rosette JJ, Michel MC, Oelke M (2008) Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur Urol 53:53\u201359","journal-title":"Eur Urol"},{"key":"947_CR50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0167-0115(96)00030-4","volume":"63","author":"G Weng","year":"1996","unstructured":"Weng G, Feinstein D, Reis D, Wahlestedt C (1996) Neuropeptide Y receptor gene regulation in mouse adrenocortical Y-1 cells. Regul Pept 63:53\u201356","journal-title":"Regul Pept"},{"key":"947_CR51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-3565(25)12267-2","volume":"276","author":"KL Widnell","year":"1996","unstructured":"Widnell KL, Self DW, Lane SB, Russell DS, Vaidya V, Miserendino MJD et al (1996) Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J Pharmacol Exp Ther 276:306\u2013315","journal-title":"J Pharmacol Exp Ther"},{"key":"947_CR52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF02249344","volume":"114","author":"SE Winders","year":"1994","unstructured":"Winders SE, Amos JC, Wilson MR, Rushing PA, Dykstra T, Coday MC (1994) Effects of chronic phenylpropanolamine infusion and termination of body weight, food consumption and water consumption in rats. Psychopharmacology 114:513\u2013519","journal-title":"Psychopharmacology"},{"key":"947_CR53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/joe.1.05866","volume":"184","author":"K Wynne","year":"2005","unstructured":"Wynne K, Stanley S, McGowan B, Bloom S (2005) Appetite control. J Endocrinol 184:291\u2013318","journal-title":"J Endocrinol"},{"key":"947_CR54","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1476-5381.2011.01363.x","volume":"163","author":"E Yulyaningsih","year":"2011","unstructured":"Yulyaningsih E, Zhang L, Herzog H, Sainsbury A (2011) NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol 163:1170\u20131202","journal-title":"Br J Pharmacol"},{"key":"947_CR55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(93)90299-Z","volume":"161","author":"M Zhang","year":"1993","unstructured":"Zhang M, Creese I (1993) Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci Lett 161:223\u2013226","journal-title":"Neurosci Lett"},{"key":"947_CR56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2011.08.069","volume":"196","author":"LL Zhang","year":"2011","unstructured":"Zhang LL, Wang JJ, Liu Y, Lu XB, Kuang Y, Wan YH, Chen Y, Yan HM, Fei J, Wang ZG (2011) GPR26-deficient mice display increased anxiety- and depression-like behaviors accompanied by reduced phosphorylated cyclic AMP responsive element-binding protein level in central amygdala. Neuroscience 196:203\u2013214","journal-title":"Neuroscience"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-012-0947-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-012-0947-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-012-0947-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T22:33:41Z","timestamp":1744238021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-012-0947-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,4]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["947"],"URL":"https:\/\/doi.org\/10.1007\/s00204-012-0947-7","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2012,10,4]]}}}